VALCHLOR® (mechlorethamine) gel is a prescription medicine used on the skin (topical) to treat people with Stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) who have received previous skin treatment. It is not known if VALCHLOR is safe and effective in children.

A medicine for
Stage IA/IB MF-CTCL that is clear

Artistic rendition of Stage IA/IB MF‑CTCL. Not an actual patient.

*In a clinical study, 119 VALCHLOR patients were evaluated over a 12-month period. 45.4% (54 out of 119 patients) experienced a partial response to the medication and 14.3% (17 out of 119 patients) achieved a complete response or clear skin in up to 5 index lesions. A complete response was achieved when the Composite Assessment of Index Lesion Severity (CAILS) score was 0, combining skin lesion ratings for redness, scaling, plaque elevation, and surface area.

VALCHLOR is a clear gel option to help patients with Stage IA/IB MF-CTCL.
Ask your doctor if VALCHLOR is right for you.

Valchlor tube

Icon 1x

Once-daily application in the comfort of your own home

Icon chronometer

Quick drying within 10 minutes (you can put it on and go about your day)

Icon sanitizing

Moisturizers may be applied (use on affected areas of your skin 2 hours before or 2 hours after using VALCHLOR)

Icon tee shirt

Non-greasy gel (once dry, unlikely to stain clothing or bedsheets)